PHOVIA owner Contact Information online
from Klox Technologies Limited
PHOVIA
US serial number:87202431
Application filling date:Oct. 13, 2016
Register:Principal
Mark type:Trademark
Status:A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additional information and/or making an initial refusal. The applicant must respond to this Office action. To view all documents i
Status date:Jan. 23, 2017
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign priority claimed:Yes
Foreign foreign application number:015895188
Foreign foreign application filling date:Oct. 06, 2016
Foreign foreign application registration country:EUROPEAN UNION
Goods and services:For: veterinary preparations for use in the treatment of skin and soft tissues, including wounds and pyoderma, namely, lotions, creams, gels or membranes
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTI
Services:veterinary preparations for use in the treatment of skin and soft tissues
including wounds and pyoderma
namely
lotions
creams
gels or membranes
Current owner owner name:Klox Technologies Limited
Current owner owner address:70 Sir John Rogerson's Quay
Dublin 2
IRELAND
Current owner legal entity type:limited company (ltd.)
Current owner state or country:IRELAND
Attorney name:Patrick J. Concannon
Attorney email:docket@nutter.com
Attorney docket number:117156-TBD
Attorney email authorized:Yes
Correspondent name address:PATRICK J. CONCANNON
NUTTER, MCCLENNEN & FISH, LLP
155 SEAPORT BOULEVARD
SEAPORT WEST
BOSTON,
MASSACHUSETTS
UNITED STATES
02210
Correspondent phone:617-439-2177
Correspondent email:docket@nutter.com
pconcannon@nutter.com
Correspondent fax:617-310-9177
Correspondent email authorized:Yes
Trademark staff tm attorney:LOVELACE, JAMES B
Trademark staff law office assigned PHOVIA:LAW OFFICE 119
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
